Essential medicines information to support complex decision-making in critical care
We are currently developing an essential resource to guide the most effective treatment for adult patients in intensive care. Due to these exceptional circumstances we are releasing as much content as we can now and at no charge, to support the NHS and MedicinesComplete users working in critical care during the COVID-19 crisis.
The complete version of Critical Illness will be published next year and available on subscription through MedicinesComplete.
This advance release of Critical Illness includes dosage and prescribing guidance for 6 drug monographs considered core for critical care units, that follow dosing outside of standard regimens and are specifically useful for adult COVID-19 patients.
- Piperacillin with tazobactam
Trusted guidance from our expert clinical editorial team
Authored using a variety of resources including primary literature, the information draws upon the clinical practice of the editors and contributors, highly experienced critical care specialists who have governed the editorial process.
Critical Illness is:
- Directly relevant to those working in critical care
I am really delighted to partner with my intensivist colleagues Dr Barbara Philips and Dr Chris Kirwan and fellow pharmacist Greg Barton to provide, what we hope is a dynamic prescribing text to support critical care at this time of intense need. I also want to thank all the antimicrobial and intensive care pharmacists for their input into this early release and finally to Pharmaceutical Press for their support in transforming our ideas into a valuable resource.
Dr Cathrine McKenzie, PhD FRPharmS
Clinical academic pharmacist in critical care / Critical Illness Editor
Practical advice to aid decision-making
Dose adjustments for acute kidney injury, augmented renal clearance and chronic kidney disease
Advice on treatment during ECMO and renal replacement therapies
Developed by team of critical care experts working in clinical practice
Support for complex decision-making in critical care
The complete version of Critical Illness will be published next year and available on subscription through MedicinesComplete. Including a wider selection of drugs, more comprehensive information as well as practical, prescribing and dosage guidance for use at the point-of-care.
To be notified when a full set of guidance is published in 2021 or if you would like to be involved in the further development of Critical Illness please sign up here.
This essential information will support the critical care multidisciplinary team, from consultants to pharmacists and nurses as well as those working on-call or in medicines information units effectively manage complex patient treatment options, specifically in this high-risk environment.